Income Statement UiPath, Inc.

Equities

PATH

US90364P1057

Software

Real-time Estimate Cboe BZX Other stock markets 13:10:00 2026-03-12 EDT			5-day change	1st Jan Change
11.56 ^USD	-6.66%		+0.48%	-29.19%

02-23	UiPath Launches Agentic AI Solutions to Break Administrative & Financial Bottlenecks for Clinicians and Healthcare Admins	CI
02-22	Uipath Appoints Arjun Laxminarasu as Head of Marketing for India and South East Asia	CI

78789342fb6a.ixlhcZgyBrWDjCAIGW81PzzG9y8dA9wzzBVs844BoGQ.428uEul7RY3543M7Sll4aGuAo3YqVp1ruE8Nm-Zj8yrCKhhH8H5uhMbreQ

Published financial data: UIPATH, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: January	2021	2022	2023	2024	2025
Revenues	608M	892M	1.06B	1.31B	1.43B
Total Revenues	608M	892M	1.06B	1.31B	1.43B
Cost of Goods Sold, Total	65.86M	163M	179M	195M	243M
Gross Profit	542M	729M	880M	1.11B	1.19B
Selling General & Admin Expenses, Total	542M	904M	912M	937M	942M
R&D Expenses	110M	271M	284M	329M	375M
Other Operating Expenses	-	54.08M	7.76M	9.89M	7M
Other Operating Expenses, Total	652M	1.23B	1.2B	1.28B	1.32B
Operating Income	-110M	-500M	-324M	-162M	-138M
Interest And Investment Income	1.15M	3.55M	27.96M	57.13M	49.42M
Net Interest Expenses	1.15M	3.55M	27.96M	57.13M	49.42M
Currency Exchange Gains (Loss)	17.45M	-8.9M	-500K	300K	6.9M
Other Non Operating Income (Expenses)	-2.94M	-4.59M	3.27M	3.23M	-3.63M
EBT, Excl. Unusual Items	-94.66M	-510M	-293M	-101M	-85.15M
Restructuring Charges	-	-	-23.45M	-2.63M	-24.73M
Merger & Related Restructuring Charges	-	-900K	-1.1M	-	-
Gain (Loss) On Sale Of Investments	-	-	-	28.25M	31.78M
EBT, Incl. Unusual Items	-94.66M	-511M	-318M	-75.82M	-78.1M
Income Tax Expense	-2.26M	14.7M	10.79M	14.07M	-4.41M
Earnings From Continuing Operations	-92.39M	-526M	-328M	-89.88M	-73.69M
Net Income to Company	-92.39M	-526M	-328M	-89.88M	-73.69M
Net Income - (IS)	-92.39M	-526M	-328M	-89.88M	-73.69M
Net Income to Common Incl Extra Items	-92.39M	-526M	-328M	-89.88M	-73.69M
Net Income to Common Excl. Extra Items	-92.39M	-526M	-328M	-89.88M	-73.69M
Per Share Items
Net EPS - Basic	-0.55	-1.16	-0.6	-0.16	-0.13
Basic EPS - Continuing Operations	-0.55	-1.16	-0.6	-0.16	-0.13
Basic Weighted Average Shares Outstanding	168M	455M	548M	564M	560M
Net EPS - Diluted	-0.55	-1.16	-0.6	-0.16	-0.13
Diluted EPS - Continuing Operations	-0.55	-1.16	-0.6	-0.16	-0.13
Diluted Weighted Average Shares Outstanding	168M	455M	548M	564M	560M
Normalized Basic EPS	-0.35	-0.7	-0.33	-0.11	-0.1
Normalized Diluted EPS	-0.35	-0.7	-0.33	-0.11	-0.1
American Depositary Receipts Ratio (ADR)	0.12	0.12	0.12	0.12	0.12
Supplemental Items
EBITDA	-99.33M	-488M	-308M	-142M	-123M
EBITA	-108M	-495M	-317M	-153M	-131M
EBIT	-110M	-500M	-324M	-162M	-138M
EBITDAR	-82.47M	-475M	-291M	-123M	-101M
Total Revenues (As Reported)	608M	892M	1.06B	1.31B	1.43B
Effective Tax Rate - (Ratio)	2.39	-2.88	-3.4	-18.56	5.64
Current Domestic Taxes	47K	80K	706K	-272K	586K
Current Foreign Taxes	5.28M	20.46M	9.22M	13.79M	14.8M
Total Current Taxes	5.32M	20.54M	9.93M	13.51M	15.39M
Deferred Domestic Taxes	-	-	-	-	593K
Deferred Foreign Taxes	-7.59M	-5.83M	861K	554K	-20.39M
Total Deferred Taxes	-7.59M	-5.83M	861K	554K	-19.79M
Normalized Net Income	-59.16M	-319M	-183M	-63.4M	-53.22M
Supplemental Operating Expense Items
Advertising Expense	21.33M	43.3M	41.5M	44.3M	45.9M
Selling and Marketing Expenses	380M	658M	677M	708M	720M
General and Administrative Expenses	162M	246M	235M	229M	222M
Research And Development Expense From Footnotes	111M	279M	288M	334M	383M
Net Rental Expense, Total	16.85M	13.49M	16.86M	18.54M	21.69M
Stock-Based Comp., COGS (Total)	2.37M	42.08M	23.75M	25.71M	30.79M
Stock-Based Comp., R&D Exp. (Total)	11.44M	136M	103M	118M	133M
Stock-Based Comp., S&M Exp. (Total)	16.36M	238M	155M	145M	135M
Stock-Based Comp., G&A Exp. (Total)	56M	99.81M	88.62M	83.42M	59.96M
Total Stock-Based Compensation	86.17M	516M	370M	372M	358M

Fiscal Period: January	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	358M	1.77B	1.4B	1.06B	879M
Short Term Investments	103M	96.42M	355M	818M	750M
Total Cash And Short Term Investments	461M	1.87B	1.76B	1.88B	1.63B
Accounts Receivable, Total	207M	327M	443M	520M	540M
Other Receivables	11.18M	10.08M	-	-	-
Total Receivables	218M	337M	443M	520M	540M
Prepaid Expenses	21.3M	29.45M	67.79M	87.78M	65.33M
Restricted Cash	7M	-	-	438K	438K
Other Current Assets, Total	27.92M	45.82M	76.24M	91.88M	103M
Total Current Assets	734M	2.28B	2.34B	2.58B	2.34B
Gross Property Plant And Equipment	50.15M	88.2M	109M	113M	139M
Accumulated Depreciation	-18.06M	-22.07M	-27.93M	-33.37M	-39.66M
Net Property Plant And Equipment	32.08M	66.13M	81.1M	80.05M	99.24M
Long-term Investments	-	19.52M	2.94M	-	130M
Goodwill	28.06M	53.56M	88.01M	89.03M	87.3M
Other Intangibles, Total	10.19M	16.82M	23.01M	14.7M	7.9M
Accounts Receivable Long-Term	2.08M	2.73M	6.52M	6.21M	3.45M
Deferred Tax Assets Long-Term	8.12M	10.63M	5.9M	4.68M	27.96M
Deferred Charges Long-Term	32.55M	117M	152M	169M	163M
Other Long-Term Assets, Total	18.94M	8.83M	31.71M	10.95M	7.4M
Total Assets	866M	2.57B	2.74B	2.95B	2.87B
Liabilities
Accounts Payable, Total	6.68M	11.52M	8.89M	3.45M	33.18M
Accrued Expenses, Total	134M	169M	176M	174M	157M
Current Portion of Leases	5.92M	1.55M	7M	8.36M	3.59M
Current Income Taxes Payable	4.02M	18.21M	8.75M	7.14M	1.63M
Unearned Revenue Current, Total	211M	297M	398M	487M	569M
Other Current Liabilities	3.78M	30.12M	27.46M	32.38M	33.68M
Total Current Liabilities	365M	528M	626M	712M	799M
Long-Term Leases	14.15M	49.84M	56.44M	58.71M	74.23M
Unearned Revenue Non Current	61.32M	68.66M	122M	161M	136M
Deferred Tax Liability Non Current	2.75M	34K	338K	133K	3.8M
Other Non Current Liabilities	4.81M	4.49M	10.12M	7.08M	6.72M
Total Liabilities	448M	651M	815M	939M	1.02B
Preferred Stock Convertible	1.22B	-	-	-	-
Total Preferred Equity	1.22B	-	-	-	-
Common Stock, Total	2K	5K	6K	6K	6K
Additional Paid In Capital	179M	3.41B	3.74B	4.02B	4.33B
Retained Earnings	-970M	-1.5B	-1.82B	-1.91B	-1.99B
Treasury Stock	-	-	-	-103M	-495M
Comprehensive Income and Other	-12.52M	10.9M	7.61M	8.82M	-4.89M
Total Common Equity	-804M	1.92B	1.92B	2.02B	1.85B
Total Equity	418M	1.92B	1.92B	2.02B	1.85B
Total Liabilities And Equity	866M	2.57B	2.74B	2.95B	2.87B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	186M	542M	557M	569M	551M
ECS Total Common Shares Outstanding	186M	541M	557M	569M	554M
Book Value / Share	-4.32	3.55	3.45	3.54	3.33
Tangible Book Value	-842M	1.85B	1.81B	1.91B	1.75B
Tangible Book Value Per Share	-4.53	3.42	3.25	3.36	3.16
Total Debt	20.08M	51.4M	63.44M	67.07M	77.82M
Net Debt	-440M	-1.83B	-1.7B	-1.81B	-1.65B
Debt Equivalent Oper. Leases	135M	108M	135M	148M	173M
Account Code - Inventory Valuation	3	3	3	3	3
Machinery, Total	22M	27.35M	34.94M	30.41M	30.8M
Full Time Employees	2.86K	4.01K	3.83K	4.04K	3.87K
Accumulated Allowance for Doubtful Accounts (Supple)	2.88M	2.57M	2.7M	1.12M	1.64M

Fiscal Period: January	2021	2022	2023	2024	2025
Net Income	-92.39M	-526M	-328M	-89.88M	-73.69M
Depreciation & Amortization - CF	8.39M	15.66M	20.3M	24.84M	8.12M
Amortization of Goodwill and Intangible Assets - (CF)	2.61M	5.12M	6.9M	8.6M	6.71M
Depreciation & Amortization, Total	11M	20.78M	27.2M	33.44M	14.83M
Amortization of Deferred Charges, Total - (CF)	42.4M	42.06M	63.03M	77.67M	94.49M
(Gain) Loss on Sale of Investments - (CF)	263K	1.95M	-1.78M	-28.25M	-31.78M
Asset Writedown & Restructuring Costs	-	-	2.88M	-	-
Stock-Based Compensation (CF)	86.17M	516M	370M	372M	358M
Provision and Write-off of Bad Debts	953K	-	-	-	-
Other Operating Activities, Total	-9.55M	-3.85M	3.9M	1.07M	337K
Change In Accounts Receivable	-98.87M	-130M	-124M	-78.91M	-26.16M
Change In Accounts Payable	1.89M	3.51M	-1.57M	-5.05M	27.86M
Change in Unearned Revenues	98.97M	105M	161M	137M	68.35M
Change in Other Net Operating Assets	-11.66M	-84.84M	-182M	-120M	-112M
Cash from Operations	29.18M	-54.96M	-9.98M	299M	321M
Capital Expenditure	-1.95M	-8.88M	-23.82M	-7.34M	-14.92M
Cash Acquisitions	-19.69M	-5.5M	-29.54M	-	-
Sale (Purchase) of Intangible assets	-1.24M	-4.18M	-	-	-
Investment in Marketable and Equity Securities, Total	-103M	-16.88M	-237M	-435M	-30.58M
Other Investing Activities, Total	-	-	1.2M	2.75M	-
Cash from Investing	-126M	-35.44M	-289M	-440M	-45.5M
Short Term Debt Issued, Total	78.59M	-	-	-	-
Total Debt Issued	78.59M	-	-	-	-
Short Term Debt Repaid, Total	-78.59M	-	-	-	-
Total Debt Repaid	-78.59M	-	-	-	-
Issuance of Common Stock	26.38M	724M	23.4M	24.3M	23.64M
Repurchase of Common Stock	-	-10.47M	-74.59M	-215M	-469M
Issuance of Preferred Stock	226M	750M	-	-	-
Other Financing Activities, Total	-1.86M	6.53M	-9.48M	-6.51M	-5.47M
Cash from Financing	250M	1.47B	-60.67M	-197M	-451M
Foreign Exchange Rate Adjustments	-16.54M	18.26M	-6.81M	-2.62M	-7.03M
Net Change in Cash	137M	1.4B	-367M	-340M	-182M
Supplemental Items
Cash Interest Paid	1.71M	691K	651K	563K	309K
Cash Income Tax Paid (Refund)	4.51M	8.45M	21M	10.82M	16.71M
Levered Free Cash Flow	88.58M	281M	152M	345M	450M
Unlevered Free Cash Flow	88.51M	281M	152M	345M	450M
Change In Net Working Capital	-21.16M	-28.47M	81.85M	29.2M	-83.55M
Net Debt Issued / Repaid	0	-	-	-	-

Fiscal Period: January	2021	2022	2023	2024	2025
Profitability
Return on Assets	-10.03	-18.18	-7.62	-3.56	-2.96
Return on Total Capital	-20.85	-25.92	-10.23	-4.98	-4.3
Return On Equity %	-30.04	-44.92	-17.09	-4.57	-3.82
Return on Common Equity	11.53	-94	-17.09	-4.57	-3.82
Margin Analysis
Gross Profit Margin %	89.16	81.71	83.13	85.09	82.97
SG&A Margin	89.23	101.33	86.19	71.6	65.86
EBITDA Margin %	-16.35	-54.71	-29.12	-10.83	-8.6
EBITA Margin %	-17.73	-55.47	-29.93	-11.73	-9.17
EBIT Margin %	-18.16	-56.04	-30.58	-12.39	-9.64
Income From Continuing Operations Margin %	-15.21	-58.91	-31.02	-6.87	-5.15
Net Income Margin %	-15.21	-58.91	-31.02	-6.87	-5.15
Net Avail. For Common Margin %	-15.21	-58.91	-31.02	-6.87	-5.15
Normalized Net Income Margin	-9.74	-35.72	-17.3	-4.85	-3.72
Levered Free Cash Flow Margin	14.58	31.53	14.37	26.39	31.47
Unlevered Free Cash Flow Margin	14.57	31.53	14.37	26.39	31.47
Asset Turnover
Asset Turnover	0.88	0.52	0.4	0.46	0.49
Fixed Assets Turnover	16.06	18.17	14.38	16.23	15.95
Receivables Turnover (Average Receivables)	3.89	3.35	2.75	2.71	2.7
Short Term Liquidity
Current Ratio	2.01	4.32	3.74	3.63	2.93
Quick Ratio	1.86	4.17	3.51	3.37	2.72
Operating Cash Flow to Current Liabilities	0.08	-0.1	-0.02	0.42	0.4
Days Sales Outstanding (Average Receivables)	94.07	109.09	132.8	134.49	135.73
Average Days Payable Outstanding	31.37	20.35	20.85	11.54	27.53
Long Term Solvency
Total Debt/Equity	4.8	2.67	3.3	3.33	4.22
Total Debt / Total Capital	4.58	2.6	3.2	3.22	4.05
LT Debt/Equity	3.38	2.59	2.94	2.91	4.02
Long-Term Debt / Total Capital	3.23	2.53	2.85	2.82	3.86
Total Liabilities / Total Assets	51.73	25.29	29.8	31.77	35.58
Total Debt / EBITDA	-0.24	-0.11	-0.22	-0.54	-0.77
Net Debt / EBITDA	5.34	3.86	5.82	14.72	16.24
Total Debt / (EBITDA - Capex)	-0.24	-0.11	-0.2	-0.51	-0.67
Net Debt / (EBITDA - Capex)	5.22	3.79	5.38	13.89	14.16
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	80.76	46.84	18.64	23.57	9.3
Gross Profit, 1 Yr. Growth %	95.12	34.56	20.7	26.49	6.58
EBITDA, 1 Yr. Growth %	-80.03	391.15	-36.86	-54.03	-13.19
EBITA, 1 Yr. Growth %	-78.67	359.48	-35.98	-51.55	-14.57
EBIT, 1 Yr. Growth %	-78.19	353.26	-35.26	-49.93	-14.96
Earnings From Cont. Operations, 1 Yr. Growth %	-82.23	468.86	-37.53	-72.63	-18.01
Net Income, 1 Yr. Growth %	-82.23	468.86	-37.53	-72.63	-18.01
Normalized Net Income, 1 Yr. Growth %	-81.28	438.76	-42.54	-65.59	-16.05
Diluted EPS Before Extra, 1 Yr. Growth %	-83.91	110.53	-48.17	-73.39	-17.44
Accounts Receivable, 1 Yr. Growth %	95.07	58.26	35.69	17.37	3.72
Net Property, Plant and Equip., 1 Yr. Growth %	-26.39	106.12	22.63	-1.29	23.97
Total Assets, 1 Yr. Growth %	70.51	196.89	6.33	8.03	-3.03
Tangible Book Value, 1 Yr. Growth %	0.64	-319.91	-2.29	5.71	-8.46
Common Equity, 1 Yr. Growth %	0.52	-339.13	-0.09	5	-8.45
Cash From Operations, 1 Yr. Growth %	-108.12	-288.38	-81.84	-3.1K	7.18
Capital Expenditures, 1 Yr. Growth %	-87.6	354.63	168.22	-69.17	103.26
Levered Free Cash Flow, 1 Yr. Growth %	-	193.71	-46.18	127.02	35.45
Unlevered Free Cash Flow, 1 Yr. Growth %	-	193.71	-46.18	127.02	35.45
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	62.92	31.99	21.08	16.21
Gross Profit, 2 Yr. CAGR %	-	62.04	27.44	24.04	16.14
EBITDA, 2 Yr. CAGR %	-	-0.93	76.1	-46.17	-36.82
EBITA, 2 Yr. CAGR %	-	-1	71.5	-44.36	-35.67
EBIT, 2 Yr. CAGR %	-	-0.56	71.3	-43.12	-34.75
Earnings From Cont. Operations, 2 Yr. CAGR %	-	0.54	88.52	-58.65	-52.63
Net Income, 2 Yr. CAGR %	-	0.54	88.52	-58.65	-52.63
Normalized Net Income, 2 Yr. CAGR %	-	0.44	75.94	-55.36	-46.26
Diluted EPS Before Extra, 2 Yr. CAGR %	-	-41.79	4.46	-62.87	-53.13
Accounts Receivable, 2 Yr. CAGR %	-	75.7	46.54	26.2	10.33
Net Property, Plant and Equip., 2 Yr. CAGR %	-	23.18	58.99	10.03	10.62
Total Assets, 2 Yr. CAGR %	-	124.99	77.67	7.17	2.35
Tangible Book Value, 2 Yr. CAGR %	-	48.77	46.59	1.63	-1.63
Common Equity, 2 Yr. CAGR %	-	55.04	54.57	2.42	-1.96
Cash From Operations, 2 Yr. CAGR %	-	-60.9	-41.51	133.27	466.72
Capital Expenditures, 2 Yr. CAGR %	-	-24.91	249.2	-9.07	-20.84
Levered Free Cash Flow, 2 Yr. CAGR %	-	-	26.01	10.65	79.02
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-	26.01	10.65	79.02
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	-	46.58	29.12	17.02
Gross Profit, 3 Yr. CAGR %	-	-	46.89	27.12	17.92
EBITDA, 3 Yr. CAGR %	-	-	-14.74	12.55	-36.88
EBITA, 3 Yr. CAGR %	-	-	-14.39	12.53	-35.81
EBIT, 3 Yr. CAGR %	-	-	-13.82	13.68	-34.96
Earnings From Cont. Operations, 3 Yr. CAGR %	-	-	-14.2	-0.91	-48.05
Net Income, 3 Yr. CAGR %	-	-	-14.2	-0.91	-48.05
Normalized Net Income, 3 Yr. CAGR %	-	-	-16.62	2.33	-44.9
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-	-44	-33.79	-51.53
Accounts Receivable, 3 Yr. CAGR %	-	-	61.2	36.09	18.21
Net Property, Plant and Equip., 3 Yr. CAGR %	-	-	23	35.64	14.49
Total Assets, 3 Yr. CAGR %	-	-	75.25	50.52	3.66
Tangible Book Value, 3 Yr. CAGR %	-	-	29.32	31.45	-1.85
Common Equity, 3 Yr. CAGR %	-	-	33.92	35.88	-1.34
Cash From Operations, 3 Yr. CAGR %	-	-	-69.72	117.23	80
Capital Expenditures, 3 Yr. CAGR %	-	-	14.78	55.49	18.9
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	-	53.33	16.86
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	-	53.33	16.86
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	-	-	33.58
Gross Profit, 5 Yr. CAGR %	-	-	-	-	33.7
EBITDA, 5 Yr. CAGR %	-	-	-	-	-24.38
EBITA, 5 Yr. CAGR %	-	-	-	-	-23.64
EBIT, 5 Yr. CAGR %	-	-	-	-	-22.89
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	-	-	-32.35
Net Income, 5 Yr. CAGR %	-	-	-	-	-32.35
Normalized Net Income, 5 Yr. CAGR %	-	-	-	-	-29.97
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	-	-	-47.85
Accounts Receivable, 5 Yr. CAGR %	-	-	-	-	38.52
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	-	-	17.89
Total Assets, 5 Yr. CAGR %	-	-	-	-	41.33
Tangible Book Value, 5 Yr. CAGR %	-	-	-	-	15.91
Common Equity, 5 Yr. CAGR %	-	-	-	-	18.21
Cash From Operations, 5 Yr. CAGR %	-	-	-	-	-2.26
Capital Expenditures, 5 Yr. CAGR %	-	-	-	-	-1.07